| Half Yearly Results of Gland Pharma (in Rs. Cr.) |
Sep '22 |
Mar '22 |
Sep '21 |
Mar '21 |
Sep '20 |
|
| Net Sales/Income from operations |
1,905.21 |
2,166.34 |
2,234.37 |
1,747.17 |
1,715.71 |
|
| Other Operating Income |
-- |
-- |
-- |
-- |
-- |
|
| Total Income From Operations |
1,905.21 |
2,166.34 |
2,234.37 |
1,747.17 |
1,715.71 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
845.18 |
1,067.54 |
979.33 |
903.27 |
845.90 |
|
| Purchase of Traded Goods |
8.54 |
13.53 |
12.14 |
6.98 |
9.22 |
|
| Increase/Decrease in Stocks |
45.63 |
-32.35 |
69.04 |
-111.83 |
-161.66 |
|
| Power & Fuel |
-- |
25.13 |
-- |
19.26 |
-- |
|
| Employees Cost |
199.16 |
175.68 |
162.89 |
160.46 |
150.90 |
|
| Depreciation |
71.58 |
58.91 |
51.39 |
49.89 |
48.89 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
241.27 |
219.12 |
198.04 |
177.08 |
161.04 |
|
| P/L Before Other |
493.86 |
638.79 |
761.56 |
542.06 |
661.43 |
|
| Other Income |
140.02 |
110.90 |
113.04 |
82.34 |
52.43 |
|
| P/L Before Int. |
633.87 |
749.69 |
874.59 |
624.40 |
713.86 |
|
| Interest |
2.62 |
3.22 |
2.03 |
2.18 |
1.23 |
|
| P/L Before Exceptional Items & Tax |
631.25 |
746.48 |
872.57 |
622.22 |
712.63 |
|
| Exceptional Items |
-- |
-- |
-- |
-- |
-- |
|
| P/L Before Tax |
631.25 |
746.48 |
872.57 |
622.22 |
712.63 |
|
| Tax |
162.17 |
187.12 |
219.77 |
157.67 |
180.18 |
|
| P/L After Tax from Ordinary Activities |
469.08 |
559.36 |
652.80 |
464.56 |
532.45 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
469.08 |
559.36 |
652.80 |
464.56 |
532.45 |
|
| Equity Share Capital |
16.47 |
16.43 |
16.42 |
16.36 |
16.33 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
28.50 |
34.05 |
39.80 |
28.40 |
32.61 |
|
| Diluted EPS |
28.49 |
-- |
39.78 |
-- |
-- |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
28.50 |
34.05 |
39.80 |
28.40 |
32.61 |
|
| Diluted EPS. |
28.49 |
-- |
39.78 |
-- |
-- |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
